Trial
NCT05518422
Role of Endothelin-1 Modulating Insulin-stimulated Blood Flow and Sympathetic Nervous System Activity in Obesity
Early Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Missouri-Columbia
Collaborators
—
Condition
Insulin Resistance
Intervention
Hyperinsulinemic, euglycemic infusion
Why stopped
No participants enrolled
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-02-20